Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308403148> ?p ?o ?g. }
- W4308403148 endingPage "134507" @default.
- W4308403148 startingPage "134507" @default.
- W4308403148 abstract "This study was designed to synthesize hybridizing molecules from ciprofloxacin and norfloxacin by enhancing their biological activity with tetrazoles. The synthesized compounds were investigated in the interaction with the target enzyme of fluoroquinolones (DNA gyrase) and COVID-19 main protease using molecular similarity, molecular docking, and QSAR studies. A QSAR study was carried out to explore the antibacterial activity of our compounds over Staphylococcus aureus a QSAR study, using descriptors obtained from the docking with DNA gyrase, in combination with steric type descriptors, was done obtaining suitable statistical parameters ( R2=87.00 , QLMO2=71.67 , and QEXT2=73.49 ) to support our results. The binding interaction of our compounds with CoV-2-Mpro was done by molecular docking and were compared with different covalent and non-covalent inhibitors of this enzyme. For the docking studies we used several crystallographic structures of the CoV-2-Mpro. The interaction energy values and binding mode with several key residues, by our compounds, support the capability of them to be CoV-2-Mpro inhibitors. The characterization of the compounds was completed using FT-IR, 1H-NMR, 13C-NMR, 19F-NMR and HRMS spectroscopic methods. The results showed that compounds 1, 4, 5, 10 and 12 had the potential to be further studied as new antibacterial and antiviral compounds." @default.
- W4308403148 created "2022-11-11" @default.
- W4308403148 creator A5006704551 @default.
- W4308403148 creator A5012130125 @default.
- W4308403148 creator A5017687029 @default.
- W4308403148 creator A5027353873 @default.
- W4308403148 creator A5050219177 @default.
- W4308403148 creator A5051336303 @default.
- W4308403148 creator A5074573336 @default.
- W4308403148 creator A5080723614 @default.
- W4308403148 creator A5091736163 @default.
- W4308403148 date "2023-02-01" @default.
- W4308403148 modified "2023-10-17" @default.
- W4308403148 title "Novel ciprofloxacin and norfloxacin-tetrazole hybrids as potential antibacterial and antiviral agents: Targeting S. aureus topoisomerase and SARS-CoV-2-MPro" @default.
- W4308403148 cites W1539306641 @default.
- W4308403148 cites W1541037889 @default.
- W4308403148 cites W1901572159 @default.
- W4308403148 cites W1978146833 @default.
- W4308403148 cites W1987161078 @default.
- W4308403148 cites W1988636074 @default.
- W4308403148 cites W1994461795 @default.
- W4308403148 cites W1998667112 @default.
- W4308403148 cites W1999145852 @default.
- W4308403148 cites W2003303885 @default.
- W4308403148 cites W2017267922 @default.
- W4308403148 cites W2034697164 @default.
- W4308403148 cites W2042043797 @default.
- W4308403148 cites W2043855224 @default.
- W4308403148 cites W2052616751 @default.
- W4308403148 cites W2054476699 @default.
- W4308403148 cites W2063553550 @default.
- W4308403148 cites W2066635884 @default.
- W4308403148 cites W2072815158 @default.
- W4308403148 cites W2077000417 @default.
- W4308403148 cites W2087329640 @default.
- W4308403148 cites W2089171980 @default.
- W4308403148 cites W2091205566 @default.
- W4308403148 cites W2108064520 @default.
- W4308403148 cites W2111955328 @default.
- W4308403148 cites W2112868591 @default.
- W4308403148 cites W2135667820 @default.
- W4308403148 cites W2147421370 @default.
- W4308403148 cites W2150697053 @default.
- W4308403148 cites W2158688828 @default.
- W4308403148 cites W2319080892 @default.
- W4308403148 cites W2344794724 @default.
- W4308403148 cites W2461441181 @default.
- W4308403148 cites W2491014331 @default.
- W4308403148 cites W2553364953 @default.
- W4308403148 cites W2769289958 @default.
- W4308403148 cites W2787575103 @default.
- W4308403148 cites W2805663875 @default.
- W4308403148 cites W2884472877 @default.
- W4308403148 cites W2909502867 @default.
- W4308403148 cites W2911530530 @default.
- W4308403148 cites W2947436708 @default.
- W4308403148 cites W2975739406 @default.
- W4308403148 cites W2993539765 @default.
- W4308403148 cites W2996393471 @default.
- W4308403148 cites W2999477800 @default.
- W4308403148 cites W3015608194 @default.
- W4308403148 cites W3015790544 @default.
- W4308403148 cites W3021518537 @default.
- W4308403148 cites W3030605102 @default.
- W4308403148 cites W3033463551 @default.
- W4308403148 cites W3033737840 @default.
- W4308403148 cites W3036021300 @default.
- W4308403148 cites W3037963889 @default.
- W4308403148 cites W3040116040 @default.
- W4308403148 cites W3046385872 @default.
- W4308403148 cites W3086463772 @default.
- W4308403148 cites W3093805839 @default.
- W4308403148 cites W3094560806 @default.
- W4308403148 cites W3107647937 @default.
- W4308403148 cites W3114040933 @default.
- W4308403148 cites W3123245089 @default.
- W4308403148 cites W3130155181 @default.
- W4308403148 cites W3157513597 @default.
- W4308403148 cites W3174748929 @default.
- W4308403148 cites W3176851129 @default.
- W4308403148 cites W3180045481 @default.
- W4308403148 cites W3185383228 @default.
- W4308403148 cites W3191865174 @default.
- W4308403148 cites W3210353967 @default.
- W4308403148 cites W3214271933 @default.
- W4308403148 cites W4210736465 @default.
- W4308403148 cites W4211126900 @default.
- W4308403148 cites W4312456311 @default.
- W4308403148 doi "https://doi.org/10.1016/j.molstruc.2022.134507" @default.
- W4308403148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36406777" @default.
- W4308403148 hasPublicationYear "2023" @default.
- W4308403148 type Work @default.
- W4308403148 citedByCount "5" @default.
- W4308403148 countsByYear W43084031482023 @default.
- W4308403148 crossrefType "journal-article" @default.
- W4308403148 hasAuthorship W4308403148A5006704551 @default.
- W4308403148 hasAuthorship W4308403148A5012130125 @default.
- W4308403148 hasAuthorship W4308403148A5017687029 @default.